Top Clinical Trials companies in Norway by Shareholders' Equity

This ranking features the top 2 Clinical Trials companies in Norway ranked by Shareholders' Equity, totaling a Shareholders' Equity of USD 20.92 M, for February 07, 2025.

Norway

Clinical Trials
Shareholders' Equity
#
Name
Shareholders' Equity
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
GENT.OL

Gentian Diagnostics ASA

1

GENT.OL
USD 14.40 M
Dec. 31, 2023 USD 4.31 4.92%

Norway
2
LIFE.OL

Lifecare AS

2

LIFE.OL
USD 6.52 M
Dec. 31, 2023 USD 1.13 -2.55%

Norway
Frequently Asked Questions
  • Which Clinical Trials company in Norway has the highest Shareholders' Equity ?

    The Clinical Trials company in Norway with the highest Shareholders' Equity is Gentian Diagnostics ASA (Oslo Stock Exchange: GENT.OL) at USD 14.40 M.

  • Which Clinical Trials company in Norway has the lowest Shareholders' Equity ?

    The Clinical Trials company in Norway with the lowest Shareholders' Equity is Lifecare AS (Oslo Stock Exchange: LIFE.OL) at USD 6.52 M.

  • What are the top 10 Clinical Trials companies in Norway by Shareholders' Equity ?

    The top 10 Clinical Trials companies in Norway by Shareholders' Equity are Gentian Diagnostics ASA and Lifecare AS.

  • What are the bottom 10 Clinical Trials companies in Norway by Shareholders' Equity ?

    The bottom 10 Clinical Trials companies in Norway by Shareholders' Equity are Lifecare AS and Gentian Diagnostics ASA.

SV Wall Street